Insider Transactions in Q2 2025 at Med Tech Acquisition Corp (MTACW)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 19
2025
|
James Emmett Young Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,175
+20.97%
|
$65,875
$5.18 P/Share
|
|
May 19
2025
|
Richard Marshak Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,597
-8.71%
|
$32,985
$5.18 P/Share
|
|
May 19
2025
|
Richard Marshak Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,428
+22.06%
|
$107,140
$5.18 P/Share
|
|
May 19
2025
|
Jodi Devlin Chief of Clinical Operations |
SELL
Open market or private sale
|
Direct |
4,764
-8.28%
|
$23,820
$5.18 P/Share
|
|
May 19
2025
|
Jodi Devlin Chief of Clinical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
24,131
+29.55%
|
$120,655
$5.18 P/Share
|
|
May 19
2025
|
Bryan F. Cox Chief of Research |
SELL
Open market or private sale
|
Direct |
4,764
-3.84%
|
$23,820
$5.18 P/Share
|
|
May 19
2025
|
Bryan F. Cox Chief of Research |
BUY
Grant, award, or other acquisition
|
Direct |
15,722
+11.24%
|
$78,610
$5.18 P/Share
|
|
May 19
2025
|
Jennifer Stevens Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
8,704
-10.08%
|
$43,520
$5.18 P/Share
|
|
May 19
2025
|
Jennifer Stevens Chief Regulatory Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,455
+24.79%
|
$142,275
$5.18 P/Share
|
|
May 19
2025
|
Sean Murphy Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,884
+26.58%
|
$224,420
$5.18 P/Share
|